BOSTON, May 21, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (Aktis or the Company), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including...
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes
News | 01. 05. 2016
Afferent Pharmaceuticals
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes.
